Diseases

T457X6S

Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela

T458X1A

Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter

T458X1D

Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter

T458X1S

Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela

T458X2A

Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter

T4594XS

Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela

T458X2D

Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter

T458X2S

Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela

T458X3A

Poisoning by other primarily systemic and hematological agents, assault, initial encounter

T458X3D

Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter

T458X3S

Poisoning by other primarily systemic and hematological agents, assault, sequela

T458X4A

Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter

T458X4D

Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter

T458X4S

Poisoning by other primarily systemic and hematological agents, undetermined, sequela

T458X5A

Adverse effect of other primarily systemic and hematological agents, initial encounter

T458X5D

Adverse effect of other primarily systemic and hematological agents, subsequent encounter

T458X5S

Adverse effect of other primarily systemic and hematological agents, sequela

T458X6A

Underdosing of other primarily systemic and hematological agents, initial encounter

T458X6D

Underdosing of other primarily systemic and hematological agents, subsequent encounter

T458X6S

Underdosing of other primarily systemic and hematological agents, sequela

T4591XA

Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter

T4591XD

Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter

T4591XS

Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela

T4592XA

Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter

T4592XD

Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter

T4592XS

Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela

T4593XA

Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter

T4593XD

Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter

T4593XS

Poisoning by unspecified primarily systemic and hematological agent, assault, sequela

T4594XA

Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter

T4594XD

Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter

T4595XA

Adverse effect of unspecified primarily systemic and hematological agent, initial encounter

T4595XD

Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter

T4595XS

Adverse effect of unspecified primarily systemic and hematological agent, sequela

T4596XA

Underdosing of unspecified primarily systemic and hematological agent, initial encounter

T4596XD

Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter

T4596XS

Underdosing of unspecified primarily systemic and hematological agent, sequela

T45AX1A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter

T45AX1D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter

T45AX1S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela

T45AX2A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter

T45AX2D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter

T45AX2S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela

T45AX3A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter

T45AX3D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter

T45AX3S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela

T45AX4A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter

T45AX4D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter

T45AX4S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela

T45AX5A

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter

T45AX5D

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

T45AX5S

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela

T45AX6A

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter

T45AX6D

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

T45AX6S

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela

T460X1A

Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter

T460X1D

Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter

T460X1S

Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela

T460X2A

Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter

T460X2D

Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter

T460X2S

Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela

T460X3A

Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter

T460X3D

Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter

T460X3S

Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela

T460X4A

Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter

T460X4D

Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter

T460X4S

Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela

T460X5A

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter

T460X5D

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter

T460X5S

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela

T460X6A

Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter

T460X6D

Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter

T460X6S

Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela

T461X1A

Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter

T461X1D

Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter

T461X1S

Poisoning by calcium-channel blockers, accidental (unintentional), sequela

T461X2A

Poisoning by calcium-channel blockers, intentional self-harm, initial encounter

T461X2D

Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter

T461X2S

Poisoning by calcium-channel blockers, intentional self-harm, sequela

T461X3A

Poisoning by calcium-channel blockers, assault, initial encounter

T461X3D

Poisoning by calcium-channel blockers, assault, subsequent encounter

T461X3S

Poisoning by calcium-channel blockers, assault, sequela

T461X4A

Poisoning by calcium-channel blockers, undetermined, initial encounter

T461X4D

Poisoning by calcium-channel blockers, undetermined, subsequent encounter

T461X4S

Poisoning by calcium-channel blockers, undetermined, sequela

T461X5A

Adverse effect of calcium-channel blockers, initial encounter

T461X5D

Adverse effect of calcium-channel blockers, subsequent encounter

T461X5S

Adverse effect of calcium-channel blockers, sequela

T461X6A

Underdosing of calcium-channel blockers, initial encounter

T461X6D

Underdosing of calcium-channel blockers, subsequent encounter

T461X6S

Underdosing of calcium-channel blockers, sequela

T462X1A

Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter

T462X1D

Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter

T462X1S

Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela

T462X2A

Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter

T462X2D

Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter

T462X2S

Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela

T462X3A

Poisoning by other antidysrhythmic drugs, assault, initial encounter

T462X3D

Poisoning by other antidysrhythmic drugs, assault, subsequent encounter

T462X3S

Poisoning by other antidysrhythmic drugs, assault, sequela